Octocog Alfa (Advate®): A Guide to Its Use in Hemophilia A

Author： Keating Gillian M.   Dhillon Sohita  

Publisher： Adis International

ISSN： 1173-8804

Source： BioDrugs, Vol.26, Iss.4, 2012-08, pp. : 269-273

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recombinant Factor VIIa (Eptacog Alfa): A Review of its Use in Congenital Hemophilia with Inhibitors, Acquired Hemophilia, and Other Congenital Bleeding Disorders

By Croom Katherine F.   McCormack Paul L.  

BioDrugs, Vol. 22, Iss. 2, 2008-01 ,pp. : 121-136

Adis International

Access to resources Recommend Favorite

Darbepoetin Alfa: Its Use in Anemia Associated with Chronic Kidney Disease

By Robinson Dean M.   Easthope Stephanie E.  

BioDrugs, Vol. 19, Iss. 5, 2005-01 ,pp. : 327-343

Adis International

Access to resources Recommend Favorite

Agalsidase Alfa: A Review of its Use in the Management of Fabry Disease

By Keating Gillian M.  

BioDrugs, Vol. 26, Iss. 5, 2012-10 ,pp. : 335-354

Adis International

Access to resources Recommend Favorite

Corifollitropin Alfa: A Review of its Use in Controlled Ovarian Stimulation for Assisted Reproduction

By Croxtall Jamie D.   McKeage Kate  

BioDrugs, Vol. 25, Iss. 4, 2011-08 ,pp. : 243-254

Adis International

Access to resources Recommend Favorite

Eculizumab: A Guide to its Use in Paroxysmal Nocturnal Hemoglobinuria

By Keating Gillian M.   Lyseng-Williamson Katherine A.   McKeage Kate  

BioDrugs, Vol. 26, Iss. 2, 2012-04 ,pp. : 125-130

Adis International

Access to resources Recommend Favorite